ArticleThe Journal of biological chemistry2026
Herpes simplex virus alkaline nuclease interacts directly with ubiquitin-specific protease 15 through a conserved C-terminal domain.
Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Herpes simplex virus replicates in the nucleus of the host cell and utilizes many cellular proteins to facilitate DNA replication. The deubiquitinating enzyme ubiquitin-specific protease 15 (USP15) is one of the most enriched proteins on replicating viral DNA and is recruited to the nucleus by a direct interaction with the viral alkaline nuclease, UL12. To better define this protein-protein interaction, we applied genetic and structural approaches and have mapped the USP15 binding domain to three conserved amino acids on the UL12 C-terminal alpha helix. A small internal deletion in this helix disrupts the UL12 interaction with USP15 but not other UL12-interacting proteins. Bioinformatic analysis reveals that this alpha helix is strongly conserved in all alphaherpesviruses but not in betaherpesviruses or gammaherpesviruses. The Kaposi's sarcoma-associated herpesvirus homolog, SOX, has an alpha helix in the same position, but the amino acid composition is highly divergent compared with UL12. Furthermore, overlaying the HerpesFolds predictions of UL12 with SOX shows high structural similarity in the nuclease domains but marked divergence in the C-terminal helix. We demonstrate that the UL12 C-terminal alpha helix can be swapped with another alphaherpesvirus UL12 helix and maintain the ability to recruit USP15 to the nucleus. Conversely, substitution with the divergent SOX helix maintains a folded protein with nuclease activity but fails to recruit USP15 to the nucleus. Analysis of the sequence between the alphaherpesvirus UL12 helices identified six identical residues. We functionally validated three of these amino acids as required for USP15 interaction. These observations identify the USP15 binding domain on UL12.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.